Samumed logo RGB-HEX_4.8.19.png
Darrin M. Beaupre, M.D., Ph.D. joins Samumed as Chief Medical Officer, Oncology
December 01, 2020 10:00 ET | Samumed, LLC.
SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Samumed, LLC, a clinical-stage biotechnology company pioneering therapeutics based on RNA alternative splicing for major diseases, announced today that...
Samumed logo RGB-HEX_4.8.19.png
Michael White, Ph.D. joins Samumed as Chief Scientific Officer
June 01, 2020 11:00 ET | Samumed, LLC.
SAN DIEGO, June 01, 2020 (GLOBE NEWSWIRE) -- Samumed, LLC, a clinical-stage biotechnology company pioneering Wnt Pathway therapeutics for major diseases, announced today that Dr. Michael White will...
Samumed Announces Publication of Phase 2 Data on Lorecivivint, Now in Pivotal Trials for Knee Osteoarthritis
May 22, 2020 09:00 ET | Samumed, LLC.
SAN DIEGO, May 22, 2020 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today the publication of results from the Phase 2a trial of lorecivivint, an investigational CLK/DYRK1A inhibitor that modulates...